TickerFacts.

Drugs Made In America Acquisition II Corp. (DMII): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$17.77M
As of 2025-12-31
-$17.93M
As of 2026-06-30
2024-12-31: -$116.7K2025-12-31: -$17.77M-$17.77M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$17.77Mn/m2026-04-15, Balance as of period end
2024-12-31-$116.7Kn/a2026-04-15, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Drugs Made In America Acquisition II Corp. (DMII)2025-12-31-$17.77Mn/m
EQV Ventures Acquisition Corp. II (EVAC)2025-12-31-$16.38Mn/m
Bain Capital GSS Investment Corp. (BCSS)2025-12-31-$15.20Mn/a
Cantor Equity Partners IV, Inc. (CEPF)2025-12-31$142.4Kn/m
Innventure, Inc. (INV)2025-12-31$204.21M-52.0%
Gores Holdings X, Inc. (GTEN)2025-12-31-$31.30Mn/m
Rice Acquisition Corp 3 (KRSP)2025-12-31-$13.31Mn/a
M3-Brigade Acquisition VI Corp. (MBVI)2025-12-31-$15.56Mn/a
American Exceptionalism Acquisition Corp. A (AEXA)2025-12-31-$19.92Mn/a

Compare DMII, EVAC, BCSS, CEPF side by side · Screen every company in Blank Checks ↗